Re: Detection of a point mutation in NQO1 (Dtdiaphorase) in a patient with colon cancer

Journal of the National Cancer Institute

Volumn 87, Issue 23, 1995, Pages 1802-1803

  Rosvold, Elizabeth A ^a   Mcglynn, Katherine A ^a   Lustbader, Edward D ^a   Buetow, Kenneth H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

COLON TUMOR; GENETICS; HUMAN; NOTE; POINT MUTATION;

COLONIC NEOPLASMS; HUMAN; NAD(P)H DEHYDROGENASE (QUINONE); POINT MUTATION;

EID: 0029638235     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.23.1802     Document Type: Letter

References (13)

1. Kolesar JM, Kuhn JG, Burris HA III. Detection of a point mutation in NQOl (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Inst 1995;87:1022-4.
2. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer. Proc Am Assoc Cancer Res 1993;34:860.
3. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Am J Hum Genet 1993;53:A350.
4. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. In press.
5. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. Centre d’Etude du Polymorphisme Humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990;6:575-7.
6. Eickelmann P, Ebert T, Warskulat U, Schulz WA, Sies H. Expression of NAD(P)H: quinone oxidoreductase and glutathione S-transferases a and it in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogen 1994;15:219-25.
7. Kolesar JM, Kuhn JG, Burris HA III. Detection of a point mutation in NQOl (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Inst 1995;87:1022-4.
8. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. In press.
9. Eickelmann P, Schulz WA, Rohde D, Schmitz-Drager B, Sies H. Loss of heterozygosity at the NAD(P)H:quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe Seyler 1994;375:439-45.
10. Edwards YH, Potter J, Hopkinson DA. Human FAD-dependent NAD(P)H diaphor-ase. Biochem J 1980;187:429-36.
11. Eickelmann P, Ebert T, Warskulat U, Schulz WA, Sies H. Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases a and it in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogen 1994;15:219-25.
12. Schlager JJ, Powis G. Cytosolic NAD(P)H: (quinone acceptor)oxidoreductase in human and normal tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 1990; 45:403-9.
13. Kolesar JM, Rizzo JR, Kuhn JG. Quantitative analysis of NQOl gene expression by RT-PCR and CE-LIF. J Cap Elec. In press.